ResMed| (RMD) insider trading

By person

28 insiders · 548 transactions

93.8×

Michael Farrell holds 93.8 times base salary in stock. $119.43M of shares against $1.27M in salary for 2026.

Salary from the company's own proxy. The shares are what Michael Farrell last reported holding, valued at $255.00, the price ResMed Common Stock was last bought or sold at on the open market here, on 23 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michael J. Farrell

Chairman and CEO

—

$98.74M (75) scheduled

−$98.74M

481,893

0.3341%

$122.88M

+138.7%

Brett Sandercock

Chief Financial Officer

—

$50.57M (99)

−$50.57M

83,495

0.0579%

$21.29M

+21.9%

Robert Andrew Douglas

Special Advisor

—

$44.71M (66) scheduled

−$44.71M

264,375

0.1833%

$67.42M

+138.0%

Peter C Farrell

Director

—

$44.06M (41) scheduled

−$44.06M

51,803

0.0359%

$13.21M

−85.1%

David Pendarvis

Chief Administrative Officer

—

$36.77M (80) scheduled

−$36.77M

89,729

0.0622%

$22.88M

+9.6%

James Hollingshead

President, Sleep Business

—

$19.39M (68)

−$19.39M

76,721

0.0532%

$19.56M

+59.2%

Justin Leong

Chief Product Officer

—

$14.42M (4)

−$14.42M

35,489

0.0246%

$9.05M

+43.0%

John P Wareham

Director

—

$12.77M (9) scheduled

−$12.77M

11,300

0.0078%

$2.88M

−13.1%

Kaushik Ghoshal

Chief Commercial Officer, SaaS

—

$10.05M (14) scheduled

−$10.05M

19,353

0.0134%

$4.94M

+149.3%

Richard Sulpizio

Director

—

$9.85M (3)

−$9.85M

17,796

0.0123%

$4.54M

−86.6%

Rajwant Sodhi

President, SaaS Business

—

$8.57M (26)

−$8.57M

26,731

0.0185%

$6.82M

+13.7%

Richard McHale

President, RC Business

—

$5.84M (9) scheduled

−$5.84M

22,982

0.0159%

$5.86M

+114.5%

Gary W Pace

Director

—

$4.62M (3) scheduled

−$4.62M

100,578

0.0697%

$25.65M

+8.0%

Carol Burt

Director

—

$2.36M (3)

−$2.36M

17,048

0.0118%

$4.35M

+36.9%

Ronald R Taylor

Director

—

$1.89M (3)

−$1.89M

24,771

0.0172%

$6.32M

+28.9%

Christopher G Roberts

Retired Director

—

$1.80M (2)

−$1.80M

523,237

0.3627%

$133.43M

+11.4%

Witte Jan De

Director

—

$1.41M (5) scheduled

−$1.41M

4,261

0.0030%

$1.09M

+203.0%

John Hernandez

Director

—

$739.29K (1) scheduled

−$739.29K

5,118

0.0035%

$1.31M

+435.4%

Michael J Rider

Global General Counsel

—

$580.25K (22) scheduled

−$580.25K

12,318

0.0085%

$3.14M

+120.1%

Karen Drexler

Director

—

$225.93K (2)

−$225.93K

10,602

0.0073%

$2.70M

+254.5%

Lucile Blaise

President, Sleep & RC Business

—

$38.06K (1) scheduled

−$38.06K

10,305

0.0071%

$2.63M

+55.5%

Anne Reiser

President - ResMed Europe

—

84,429

0.0585%

$21.53M

−7.2%

Resmed Inc entity

Director

—

13,823

0.0096%

$3.52M

+7.4%

Harjit Gill

Director

—

10,940

0.0076%

$2.79M

+331.9%

Aaron Bloomer

Chief Financial Officer

—

9,072

0.0063%

$2.31M

—

Desney Tan

Director

—

6,002

0.0042%

$1.53M

+527.8%

Christopher DelOrefice

Director

—

2,423

0.0017%

$617.87K

—

Nicole Mowad-Nassar

Director

—

777

0.0005%

$198.14K

—

ResMed|

What the insiders did Net selling

By person